Author
Listed:
- Hyun Jung Jun
(Beth Israel Deaconess Medical Center)
- Vicky A. Appleman
(Beth Israel Deaconess Medical Center)
- Hua-Jun Wu
(Dana-Farber Cancer Institute
Harvard T. H. Chan School of Public Health)
- Christopher M. Rose
(Harvard Medical School)
- Javier J. Pineda
(Harvard Medical School)
- Alan T. Yeo
(Tufts University School of Medicine)
- Bethany Delcuze
(Tufts University School of Medicine)
- Charlotte Lee
(Dana-Farber Cancer Institute
Harvard T. H. Chan School of Public Health)
- Aron Gyuris
(Beth Israel Deaconess Medical Center)
- Haihao Zhu
(Tufts Medical Center)
- Steve Woolfenden
(Tufts Medical Center)
- Agnieszka Bronisz
(Harvard Medical School)
- Ichiro Nakano
(University of Alabama at Birmingham)
- Ennio A. Chiocca
(Harvard Medical School)
- Roderick T. Bronson
(Dana-Farber/Harvard Cancer Center)
- Keith L. Ligon
(Dana-Farber Cancer Institute)
- Jann N. Sarkaria
(Mayo Clinic)
- Steve P. Gygi
(Harvard Medical School)
- Franziska Michor
(Dana-Farber Cancer Institute
Harvard T. H. Chan School of Public Health)
- Timothy J. Mitchison
(Harvard Medical School)
- Al Charest
(Beth Israel Deaconess Medical Center
Harvard Medical School)
Abstract
Glioblastoma multiforme (GBM) is an aggressive primary brain cancer that includes focal amplification of PDGFRα and for which there are no effective therapies. Herein, we report the development of a genetically engineered mouse model of GBM based on autocrine, chronic stimulation of overexpressed PDGFRα, and the analysis of GBM signaling pathways using proteomics. We discover the tubulin-binding protein Stathmin1 (STMN1) as a PDGFRα phospho-regulated target, and that this mis-regulation confers sensitivity to vinblastine (VB) cytotoxicity. Treatment of PDGFRα-positive mouse and a patient-derived xenograft (PDX) GBMs with VB in mice prolongs survival and is dependent on STMN1. Our work reveals a previously unconsidered link between PDGFRα activity and STMN1, and highlight an STMN1-dependent cytotoxic effect of VB in GBM.
Suggested Citation
Hyun Jung Jun & Vicky A. Appleman & Hua-Jun Wu & Christopher M. Rose & Javier J. Pineda & Alan T. Yeo & Bethany Delcuze & Charlotte Lee & Aron Gyuris & Haihao Zhu & Steve Woolfenden & Agnieszka Bronis, 2018.
"A PDGFRα-driven mouse model of glioblastoma reveals a stathmin1-mediated mechanism of sensitivity to vinblastine,"
Nature Communications, Nature, vol. 9(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-05036-4
DOI: 10.1038/s41467-018-05036-4
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-05036-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.